Category: Accuray Inc.
The FDA grants 510(k) clearance to Accuray's CyberKnife M6 radiosurgery device for treating cancerous tumors.
Accuray (NSDQ:ARAY) won 510(k) clearance from the FDA for the latest iteration of its CyberKnife radiosurgery device.
Chief commercial officer Kelly Londy told MassDevice.com that the Sunnyvale, Calif.-based medical device company is launching the product immediately.
Euan Thomson abruptly resigns from Sunnyvale, Calif.-based medical device maker Accuray, will be replaced by former Mentor Corp., Immucor CEO.
Medical device company Accuray (NSDQ:ARAY) said CEO Euan Thomson has left the company and will be replaced by Joshua Levine, the former CEO of Mentor Corp. and Immucor.
Medical device maker Accuray reports that its losses jumped 170% during fiscal 2012, cautioning that Q1 results will be dramatically lower as it ramps up for a new product launch this fall.
Medical device company Accuray (NSDQ:ARAY) said it's completed a "year of transition" as it looks to the release of 2 new products in October, which it says will help "change the dynamic" of the radiosurgery market.
The prolonged slump in the U.S. defibrillator market appears to have stabilized, according to medical device company Medtronic.
Medtronic (NYSE:MDT) said the slump that's hit its bread-and-butter cardiac rhythm management division where it hurts appears to have stabilized, despite the 5% sales slide during its fiscal 1st quarter.
The best way to beat Intuitive Surgical out of the corner it has on the prostate cancer treatment market is by amping up the aggression, radiosurgery veteran and Varian chief medical officer John Adler tells MassDevice.com.
Radiosurgery innovator and medtech veteran John Adler is ready for a fight.
The outspoken inventor of Accuray's (NSDQ:ARAY) CyberKnife system, as well as the company's founder and former CEO, Adler is an evangelist for radiosurgery and its potential in a variety of applications.
Prostate surgery with robotic assistance may cause less impotence and incontinence than laparoscopic surgery, according to a small Italian study.
Robot assisted prostate surgery may lower rates of urinary incontinence and post-surgery impotence when compared with minimally invasive laparoscopy, according to a small Italian study.
The study only comprised 120 patients who were randomized to receive a prostatectomy with either an unnamed robot assistant or with tiny tools manipulated by hand. All surgeries were performed by a single surgeon.